Table 3. Clinical and pathological characteristics and outcome of patients with recurrence disease (n=8).

Patients	Age (yr)	Parity	Tumor size (cm)	Initial surgery	Recurrence location	Recurrence treatment	Recurrence pathology	Outcome
1	35	3	16	Myomectomy	Uterus	TAH	STUMP	ANED
2	47	0	5	Myomectomy	Uterus	TAH+BSO	STUMP	ANED
3	38	0	9	Myomectomy	Uterus	Myomectomy	STUMP	ANED
4	45	2	13	TAH+BSO	Pelvic RP mass	Mass excision	STUMP	ANED
5	35	0	2	Hysteroscopic myomectomy	Uterus	Hysteroscopic myomectomy	STUMP	ANED
6	52	0	20	Myomectomy	Pelvic+ upper abdominal mass	Debulking+ chemotherapy	LMS	DOD
7	30	1	4	Myomectomy	Uterus	TAH	STUMP	ANED
8	39	2	11	TAH+USO	Pelvic RP mass	Mass excision	STUMP	ANED

STUMP, uterine smooth muscle tumors of uncertain malignant potential; TAH+BSO, total abdominal hysterectomy+bilateral salpingo-oophorectomy; TAH+USO, total abdominal hysterectomy+unilateral salpingo-oophorectomy; ANED, alive with no evidence of disease; RP, retroperitoneal; CT, chemotherapy; DOD, dead of disease; LMS, leiomyosarcoma.